Klener P
1. interní hemato-onkologická klinika 1. LF a VFN a UHKT, Praha.
Klin Onkol. 2010;23(1):14-20.
Angiogenesis is a complex process which is critical for the growth, invasion and metastasis of tumors. In the past ten years numerous new agents have been developed as angiogenesis inhibitors. In the review, angiogenesis inhibitors are classified by their targeted area of the angiogenic process. The role of VEGF and its receptors is described in detail, but other antiangiogenic strategies such as inhibition of endothelial proliferation, inhibition of matrix metalloproteinases and use of vascular disrupting agents are also reviewed.
血管生成是一个复杂的过程,对肿瘤的生长、侵袭和转移至关重要。在过去十年中,已经开发出许多新型药物作为血管生成抑制剂。在这篇综述中,血管生成抑制剂根据其在血管生成过程中的靶向区域进行分类。详细描述了血管内皮生长因子(VEGF)及其受体的作用,但也综述了其他抗血管生成策略,如抑制内皮细胞增殖、抑制基质金属蛋白酶以及使用血管破坏剂。